Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 12Recruiting 8Active not recruiting 4Withdrawn 1Unknown 1Terminated 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Myeloid 1

Conditions

Breast Neoplasms 9Carcinoma, Non-Small-Cell Lung 6Carcinoma, Hepatocellular 6Recurrence 5Pancreatic Neoplasms 5Neoplasms 5Stomach Neoplasms 4Solid Tumor 4Melanoma 4Liver Neoplasms 4Advanced Solid Tumors 4Neoplasm Metastasis 3Nasopharyngeal Carcinoma 3Leukemia, Myeloid, Acute 3Biliary Tract Neoplasms 3Advanced Solid Tumor 3Uterine Cervical Neoplasms 2Triple Negative Breast Neoplasms 2Thoracic Neoplasms 2Precursor Cell Lymphoblastic Leukemia-Lymphoma 2Ovarian Neoplasms 2Multiple Myeloma 2Lymphoma, Large B-Cell, Diffuse 2Lung Neoplasms 2Esophageal Squamous Cell Carcinoma 2Esophageal Neoplasms 2Endometrial Neoplasms 2Colorectal Neoplasms 2Urinary Bladder Neoplasms 1Squamous Cell Lung Cancer 1

Interventions

Azacitidine 10Decitabine 9Cyclophosphamide 9Cytarabine 7Tacrolimus 6Antilymphocyte Serum 6fludarabine phosphate 5Mycophenolic Acid 5Melphalan 5Busulfan 5fludarabine 4Whole-Body Irradiation 4Peripheral Blood Stem Cell Transplantation 4Idarubicin 4Rituximab 3Polymerase Chain Reaction 3Lenalidomide 3Filgrastim 3venetoclax 2sargramostim 2Tretinoin 2Radiotherapy 2Methylprednisolone 2Methotrexate 2Flow Cytometry 2Etoposide 2Cyclosporine 2Cord Blood Stem Cell Transplantation 2Clofarabine 2Blood Specimen Collection 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Unknown × Myelodysplastic Syndromes × Injections × Clear all
NCT06008405 2023-09-06

Clinical Trial Evaluating the Safety of the TQB2928 Injection Combination Therapy

Chia Tai Tianqing Pharmaceutical Group Co., Ltd.

Phase 1 Unknown
48 enrolled
MyeloidOther hematologic neoplasm

Myelodysplastic Syndromes, Leukemia, Myeloid, Acute

Data powered by HemOnc (CC BY 4.0) Colophon âš¡